We have developed an epithelial cell carcinoma model for studying efficacy of IFNc gene therapy and have identified components of IFNc-signaling pathway responsible for its direct anti-tumor actions. The tumor results from ectopic expression of SV40 Large T-Antigen (SV40 T-Ag) oncogene in lens of transgenic mouse (aT3) and complete regression of the tumor is induced by targeting expression of IFNc into malignant lens cells. Inflammatory cells are absent in lens of aT3 or DT (co-expressing IFNc and SV40-T-Antigen) mice and the transformed lens cells are non-immunogenic, suggesting non-involvement of immunologic cells. We show that IFNc has direct growth-inhibitory effects on tumor cells, induces death of tumor cells by apoptosis and that these effects are mediated by two transcription factors, IRF-1 (interferon-regulatory factor-1) and ICSBP (interferon-consensus sequence-binding protein) induced by IFNc. Furthermore, stable transfection with ICSBP or IRF-1 construct inhibits lens carcinoma cell growth by upregulating Caspase-1, p21 WAF1 and p27 expression. In contrast, tumor progression in aT3 lens correlates with inhibition of IRF-1 and ICSBP expression. Our results suggest that IFNc gene therapy maybe effective in malignant diseases for which DNA tumor viruses are etiologic agents and that antitumor actions of IRF-1/ ICSBP can be exploited therapeutically to circumvent adverse clinical effects associated with IFN therapy.
Introduction
Carcinomas account for over 90% of malignant tumors in humans and may spontaneously arise from the prostate, bladder, breast, ovary, lung, pancreas, esophagus or gastrointestinal tract. The etiology of human epithelial cell carcinomas is poorly understood. However, persistent infections with oncogenic viruses have been implicated as etiologic agents of head and neck cancers (Mork et al., 2001; Bjorge et al., 2002) , malignant pleural mesothelioma (Hughes, 2005) and nasopharyngeal carcinoma (Young and Rickinson, 2004) . These observations have led to development of animal models of virus-induced epithelial cell carcinomas for understanding oncogenic mechanisms in susceptible tissues. Transgenic (TR) mice expressing E6 or E7 protein of high-risk Human papillomaviruses (HPVs) or the SV40 Large T-Antigen (SV40 T-Ag) reveal that viral oncogenes induce epithelial cell cancers by interfering with mechanisms that regulate proliferation and programmed death of epithelial cells Schaeffer et al., 2004; Schreiber et al., 2004) . Although significant in-roads have been made in development of anticancer agents, few therapies with proven efficacy are available for highly aggressive epithelial cell carcinomas and for majority of these patients, prognosis following diagnosis is poor (Vilchez and Butel, 2004; Young and Rickinson, 2004; Hughes, 2005) . Targeting expression of proteins that control cell cycle progression or promote apoptosis into neoplastic cells localized in specific tissues of TR mice provides a powerful tool for validating the efficacy of potential antineoplastic agents Gabril et al., 2005; Garcia-Espana et al., 2005) .
Interferons (IFNs) possess potent growth inhibitory effects on tumor cells and there has been significant interest in their use in cancer therapy since their discovery in 1957 (Isaacs and Lindenmann, 1957) . At present, IFNs are licensed agents for hematologic, as well as for solid tumors including multiple myeloma, non-Hodgkins lymphoma, metastatic renal cell carcinoma, cervical cancer, thyroid carcinoma, chronic myelogenous leukemia, metastatic melanoma and Kaposi's sarcoma (Pfeffer et al., 1998; DeVita Jr et al., 2001; Tagliaferri et al., 2005) . However, clinical use of IFNs is severely limited by severe toxicity such as, granulocytopenia, liver toxicity, neurological disorders, fatigue and this has led to the search for alternative strategies that would circumvent toxic effects of IFN therapy by identifying and using transcription factors that can directly activate antitumor mechanisms of IFNs. Type I (IFNa/b) and Type II (IFNg) IFNs exert their effects by binding to cognate receptors on target cells and the IFN signal is coupled to gene transcription through activation of Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathways (Darnell, 1997) . Although the two types of IFNs recognize distinct receptors, they have overlapping biological effects stemming from their common dependence on STAT1 for regulation of gene transcription. Immediate targets of activated STAT1 protein are IFN regulatory factors (IRFs) (Nguyen et al., 1997) and two IRF members, IRF-1 and IFN consensus sequence binding protein (ICSBP) or IRF-8 possess tumor suppressor activities (Boultwood et al., 1993; Willman et al., 1993; Holtschke et al., 1996) . It is therefore not clear whether antitumor effects of IFNs derive from activated STAT1 or these two IFN-inducible IRF tumor suppressors that have also been implicated in several biological effects attributed to IFNs (Taniguchi et al., 1995) .
Our goal in this study was to develop an animal model of SV40-induced neoplasia to investigate the potential of cytokine gene therapy in treatment of cancers for which a viral oncogene is the etiologic agent. Specifically, we have utilized a TR mouse model of SV40-T-Ag-induced lens epithelial cell carcinoma (aT3) to investigate whether targeting expression of IFNg directly into malignant cells can induce regression of an undifferentiated epithelial cell tumor. The data presented provide evidence of IFNg-induced regression of the tumor and indicate that STAT1 is not necessary for downstream actions IFNg but is required mainly for the transactivation of IRF-1 and ICSBP genes. We further show that growth inhibitory and proapoptotic effects of IRF-1 and ICSBP are mediated, in part, through transcriptional activation of p21
WAF1
, p27 and caspase-1 genes, suggesting that IFNg-inducible tumor suppressor can substitute for IFNg and directly activate antitumor mechanisms in malignant cells.
Results

Generation and phenotype of SV40 T-Ag/IFNg double transgenic (DT) mice
The SV40-TAg/IFNg (DT) mouse was derived by mating a mouse strain expressing SV40-TAg in lens (aT3) (Lakso et al., 1992) with another expressing IFNg in lens (IFNg-TR) (Egwuagu et al., 1994) . aT3 mice has heritable lens epithelial tumors Lakso et al., 1992) , whereas IFNg-TR mouse presents severe microphthalmia (Egwuagu et al., 1994; Li et al., 1999a) . The offspring of aT3 and IFNg-TR mice were mated for seven generations to establish the DT strain and eyes or lenses of these mice are of intermediate size between aT3 and IFNg-TR phenotypes (Figure 1a) . The DT phenotype is characterized by stable ectopic expression of IFNg, small (SV40-tAg) and large SV40 tumor antigen (SV40-TAg) mRNAs in lens (Figure 1b) . We further show that the SV40-TAg protein is synthesized in aT3 and DT lenses (arrows; Figure 1c and d). It is noteworthy that equivalent level of SV40-TAg expression is detected in aT3 or DT mouse lens and although intense nuclear staining of SV40-TAg is detected in significant numbers of lens cells in E17 aT3 or DT lens, expression of the protein is not detectable in some cells. This observation is consistent with published results of immunohistochemical staining of SV40-TAg protein in TR rats expressing SV40-TAg under control of probasin promoter (Asamoto et al., 2001; Jin et al., 2004) , TR mice expressing SV40-TAg under control of ovarian-specific promoter 1 (Garson et al., 2003) or HEK293T cell line expressing SV40-TAg (Jin et al., 2004 ). An explanation that has been suggested for differences in SV40-TAg expression detected and one that pertains to our result is that the amount of SV40-TAg in nucleus may vary at different stages of the cell cycle.
IFNg does not prevent lens cell transformation but induces regression of lens tumor We ensured that expression of SV40 T-Ag and IFNg transgenes is initiated at the same time in the lens epithelial cells by using the same lens-specific aA-crystallin (À366 to þ 46) promoter element ; this allowed us to determine whether IFNg can prevent oncogenic transformation or if it functions mainly to inhibit tumor progression. Morphology of the wild-type (WT) mouse lens is shown in Figure 2a (Figure 2n-p) . In contrast, the entire aT3 lens is invaded by neoplastic cells (Figure 2k-m) , eventually resulting in a liquefied lens with residual necrotic cells (see Figures 1a and 2k) . These results suggest that IFNg does not prevent oncogenic transformation of the lens cell but inhibits tumor progression.
IFNg-induced regression of lens tumor does not require immunological effector cells Expression of both transgenes coincides temporally with activation of endogenous aA-crystallin gene at E12.5 Mahon et al., 1987) . We therefore expected aT3 and DT mice to be immunologically tolerant of SV40-TAg protein because its expression precedes establishment of a functional immune system which occurs at BE16 in the mouse (Janeway et al., 1999) . Lymphocytes from WT, aT3 or DT mouse strains respond vigorously to stimulation with PPD (data not shown), indicating that all three mouse strains are capable of mounting cellular immune responses against foreign proteins. However, SV40 T-Ag-primed spleen (Figure 3a ) or cervical lymph node ( Figure 3b ) lymphocytes from WT mice respond vigorously to SV40-TAg upon challenge, whereas cells from aT3 or DT mice are unresponsive ( Figure 3 ). Unresponsiveness of aT3 and DT lymphocytes is consistent with reports showing that expression of SV40-TAg early in development induces immunological tolerance to the protein (Jolicoeur et al., 1994; Ye et al., 1994) . Furthermore, results of immunohistochemical analyses of aT3 or DT lens with antibodies specific for inflammatory cells markers (e.g. CD4, CD8) were negative (data not shown), suggesting that SV40 T-Agtransformed lens cells are not immunogenic and therefore tumor regression in DT lens cannot be attributed to immunological effector cells.
Expression of IRF-1 and ICSBP transcription factors is induced in DT mouse lens
Western blot analysis reveals marked activation of STAT1 in IFNg-TR and DT but not in WT lens extracts, indicating that the IFNg transgene is functionally active in the lens (Figure 4) . Interestingly, only a modest activation of STAT1 is observed in the aT3 lens and it is not clear whether this represents an intrinsic antiproliferative response of lens cells to oncogenic transformation. IRF family of transcription factors are immediate targets of activated STAT1 (Nguyen et al., 1997) and two IRFs, IRF-1 and ICSBP possess tumor suppressive activities, whereas another IRF member, IRF-2 is oncogenic Holtschke et al., 1996) . We therefore examined whether the lens phenotype of aT3 or DT mouse correlate with the levels of these cell cycle regulatory proteins. Compared to WT lens, expression of IRF-1 and ICSBP is upregulated in DT and IFNg-TR but not aT3 lens ( Figure 4 ) and ICSBP is down-regulated in the aT3 lens ( Figure 4a ). On the other hand, IRF-2 level is similar in all four mouse strains, suggesting that IFNg differentially induces expression of tumor suppressive IRFs. We also examined whether the lens phenotypes correlate with induction of the tumor suppressor proteins Rb and p53 in the lens by IFNg. In concert with the high level of proliferating cells present in the aT3 lens, we observe very high levels of transcription of the E2F-1 gene ( Figure 4b ). However, no significant difference in mRNA levels of Rb or p53 is observed in lenses of aT3 and DT mice, suggesting that these bona fide tumor suppressors have little or no role in regression of the lens tumor.
Regression of lens neoplasm is mediated by activation of apoptosis in DT lens
Apoptosis is an important mechanism used by many cell types to regulate tumor growth and IFNg is a potent inducer of this pathway (Kano et al., 1999; Detjen et al., 2001) . We therefore analysed newborn mouse lenses by the TUNEL assay to determine whether regression of lens epithelial cell tumor derives from activation of apoptotic pathways in DT lens. We observe significant numbers of cells undergoing apoptosis in DT (Figure 5f ) compared to WT, IFNg-TR or aT3 lens (Figure 5e ), suggesting that IFNg activates apoptotic pathways in SV40-TAg-transformed lens cells. We further show that activation of apoptosis is accompanied by enhanced expression in the DT lens of the IRF-1-inducible protein, caspase-1 (Figure 5a and b) and this is in line with recent reports (Horiuchi et al., 1999; Bowie et al., 2004) . Because FAS and FASL are constitutively expressed in the eye, we examined whether FAS/FASL apoptosis pathway is induced in the DT lens. In contrast to robust induction of caspase-1, expression of the IFNg-independent FAS gene is unaffected (Figure 5b ). However, absence of upregulation of FAS merely 
; arrows in (f, g, i, j) indicate proliferating lens cells stained by PCNA or BrdU Abs. L, lens; C, cornea; R, retina; V, vitreous; *, lens bow and equatorial region. H&E staining; original magnification is indicated at the bottom right.
indicates that it is not induced by ectopic IFNg and does not necessarily rule out its role in activation of apoptosis in the lens. It is noteworthy that although expression of IRF-1 and caspase 1 is upregulated in the IFNg-TR and DT mouse lenses, there is no evidence of apoptosis in IFNg-TR lens. In fact, absence of apoptosis in the IFNg-TR mouse lens is consistent with reports indicating that the main effect of IFNg in TR mouse and rat strains with targeted expression of IFNg to the lens is inhibition of lens differentiation (Egwuagu et al., 1994 Li et al., 1999a) . These observations are also consistent with results from in vitro studies showing that IFNg induces expression of ICSBP, IRF-1 and caspase 1 in normal and aTN4-1 lens cells (Awasthi and Wagner, 2004; Ebong et al., 2004a; Li et al., 1999a) but induces apoptosis only in transformed aTN4-1 lens cells (Awasthi and Wagner, 2004) .
Inhibition of growth of SV40 T-Ag-transformed lens cells is mediated by IRF-1 and ICSBP
We generated SV40-TAg-transformed lens epithelial cells with overexpression of IRF-1 or ICSBP to directly examine whether growth of these cells are affected by either tumor suppressor. Representative clones of SV40 T-Ag-transformed lens cells with stable overexpression of IRF-1 (aTN4-1/IRF-1) or ICSBP (aTN4-1-ICSBP) are shown in Figure 6a (lanes 2 and 3) and Figure 6b (lanes 2 and 3), respectively. Because both IRF-1 and ICSBP are constitutively expressed in the lens (Li et al., 1999a, b) , we also examined whether there is crossregulation of either factor in these overexpression models. We show that IRF-1 is upregulated in aTN4-1/ICSBP clones suggesting that enhanced expression of ICSBP has a positive feedback effect on IRF-1 expression. Analysis of the whole cell extracts further indicates that STAT1 is not constitutively activated in SV40 T-Ag-transformed cells (aTN4-1) (Figure 6d , lane 1) but is induced following stimulation with IFNg ( Figure 6d, lane 4) . It is noteworthy that pSTAT1 is not detected in aTN4-1/IRF-1 (Figure 6d, lane 2) or aTN4-1/ICSBP cells (Figure 6d, lane 3) , suggesting that any effects on the growth of these cells cannot be attributed to STAT1.
The aTN4-1/IRF-1 or aTN4-1/ICSBP cells are therefore ideally suited for investigating intrinsic growth-inhibitory effects of IRF-1 or ICSBP and allow direct examination of whether pSTAT1 is required for the growth-inhibitory effects of these IRFs on SV40-TAg-transformed lens cells. aTN4-1 line is a highly proliferating cell line compared to other lens epithelial cell lines such as CRLE2, 1AMLE or NKR11 (Egwuagu, unpublished results) . In a recent study, IFNg was found to inhibit growth of aTN4-1 cells and to induce significant numbers of the aTN4-1 to undergo apoptosis upon prolonged exposure (after day 3) of the cells to this cytokine (Awasthi and Wagner, 2004) . Consistent with that study, we show here that IFNg induces significant growth inhibition of the aTN4-1 cells (Figure 7a ). To further characterize potential role of IRF-1 or ICSBP in regulation of the growth of SV40-TAg-transformed lens cells, we compared the growth rates of aTN4-1, aTN4-1/ IRF-1 or aTN4-1/ICSBP by the [ of ICSBP is most pronounced, as by the 48 h time point, we still observe significant decrease in growth of aTN4-1/ICSBP cells compared to aTN4-1 or aTN4-1/IRF-1 cells. As shown in Figure 7c , the growth-inhibitory effects on the aTN4-1 cells may derive, in part, from upregulating expression of proteins that control cell cycle events. Either IRF-1 or ICSBP induces expression p21 WAF1 in aTN4-1 and the levels are higher than that induced by IFNg, suggesting that enhanced expression of this cyclin-dependent kinase (CDK) inhibitory protein in transformed lens epithelial cells is mediated by these IRF transcription factors. In contrast to p21 WAF1 that is induced by IRF-1 and ICSBP, expression of another CDK inhibitor, p27, is differentially activated by ICSBP but not IRF-1 (Figure 7c) . Moreover, effects of ICSBP or IRF-1 are specific as expression of other cell cycle regulatory proteins, such as, cyclin D, Cdk4, INK (data not shown) and E2F (Figure 4a) , is unaffected.
IRF-1 interacts with SV40 T-Ag HPV E6, E7 and SV40 T-Ag oncogenic proteins induce neoplastic transformation, in part, by interacting with and squelching biological activities of critical cellular proteins such as p53 or retinoblastoma tumor suppressor proteins. HPV E7 and E6 have recently been shown to bind and to inactivate transactivation functions of IRF-1 and IRF-3, respectively, suggesting that IRFs are targets of oncogenic proteins (Ronco et al., 1998; Park et al., 2000) . We therefore performed pull-down assays on extracts derived from aTN4-1, aTN4-1/IRF-1 or aTN4-1/ICSBP with SV40-TAg Abs to investigate whether IRF-1 and/or ICSBP are cellular targets of SV40 T-Ag oncoprotein. In immunoblot analysis of immunoprecipitates obtained using ICSBP Abs, we do not detect interaction between ICSBP with SV40-TAg in any of the extracts (data not shown). However, similar pull-down assay using IRF-1 Abs reveals a strong band in extracts from aTN4-1/IRF-1 and a weak band from aTN4-1/ICSBP but not in aTN4-1 extracts, suggesting that IRF-1 may be a cellular target of SV40-TAg. Although regression of the lens tumor may derive in part from enhanced expression of IRF-1 and squelching of the oncogenic activity of SV40-TAg by IRF-1 in the DT lens cells, the bulk of data provided suggest that antiapoptotic and growth inhibitory effects of ICSBP and IRF-1 are the major sources of antitumor activities.
Discussion
Although lens tumors are not known to occur naturally, the non-innervated, avascular vertebrate lens that is comprised of a single epithelial cell type at varying stages of differentiation (McAvoy, 1980; Piatigorsky, 1981) is well suited for studying how oncogenes subvert cellular mechanisms that control growth of normal epithelia. In this study, mice that develop lens epithelial cell carcinoma as a result of targeted expression of SV40 T-Ag oncogene in the lens (aT3) were used to investigate whether IFNg can induce regression of an invasive tumor and identify components of the IFNg signal transduction pathway that might be responsible for the direct antitumor effects of this cytokine on malignant cells.
We show here that targeting expression of IFNg to the malignant lens cells very early in development rescues the neoplastic cell phenotype and induces regression of the tumor. In either the aT3 or DT mouse lens, inflammatory cells are not detected and lymphocytes from these mice do not mount proliferative responses against the SV40-TAg oncogenic protein (Figure 3) , suggesting that regression of the lens tumor derives from direct antitumor effects of IFNg on the malignant cells. These observations are consistent with development of immunological tolerance to the lens carcinoma cells and in line with published reports showing that SV40-TAginduced tumors are not immunogenic in TR mice if expression of the transgene is initiated prior to establishment of a functional immune system (BE16 in the mouse) (Jolicoeur et al., 1994; Ye et al., 1994) . Malignant transformation of lens cells, despite the fact that expression of IFNg and SV40-TAg is initiated at the same time in the lens, indicates that intrinsic antitumor activities of IFNg could not prevent transformation of the lens cells but function primarily in inhibiting tumor cell growth. Inability of IFNg to prevent transformation of lens cells by SV40-TAg can be attributed to temporal delay in activating IFNg signaling pathway, vis-a-vis, expression of the SV40-TAg protein. Whereas oncogenic activity of SV40-TAg commences immediately following its expression, IFNg synthesized by the lens cell has to be secreted before it can manifest its biological activity. It is only after binding of IFNg to its cognate receptor on the cell or neighboring lens cells is IFNg signal transduction cascade activated. Thus, the interval between initiation of SV40-TAg protein synthesis and activation of STAT1/IRF-1/ICSBP pathways may be sufficient to allow transformation of lens cells by SV40-TAg. Nonetheless, the tumorigenic activity of SV40-TAg is progressively curtailed with increasing levels of activation of JAK/STAT pathway.
Rescue of the neoplastic lens phenotype correlates with enhanced expression of IRF-1 and ICSBP in the DT lens with no effect on the level of IRF-2, indicating that an important consequence of ectopic lens expression of IFNg is to drastically increase cellular amounts of IFNg-inducible tumor suppressors (Figure 4) . In contrast, expression of ICSBP or IRF-1 is repressed in aT3 mouse lens (Figure 4a) . In fact, we show here for the first time that SV40-TAg interacts with IRF-1 (Figure 7d ), suggesting that SV40-TAg may target the IRF-1 protein for degradation. However, additional studies are required to determine the extent to which interactions between SV40-TAg and IRF-1 contribute to antitumor action of IRF-1 in the DT lens and whether the mechanism involves sequestration of the SV40-TAg protein through enhanced expression of IRF-1.
Analysis of SV40-TAg-transformed lens cells with overexpression of ICSBP (aTN4-1/ICSBP) or IRF-1 (aTN4-1/IRF-1) reveal that ICSBP, and to a lesser extent IRF-1, inhibits growth of transformed lens cells (Figure 7b ). These results suggest that a major pathway by which IFNg induces regression of lens carcinoma is by enhancing expression of growthregulatory IRF proteins in the lens. In context of the functional significance of elevated levels of ICSBP and IRF-1 in DT lens cells, it is important to note that IRFs play major roles in amplifying biological effects of IFNg. Although immediate effects of IFNg are mediated by binding of activated STAT1 to GAS sites of IFNg-target genes, IFNg also activates a late-acting transcription factor that binds to IFN-stimulated response elements (ISRE) and several IRFs regulate gene transcription through binding ISRE motifs in promoter of target genes (Miyamoto et al., 1988) . Unlike IRF-1, ICSBP does not bind directly to the ISRE motif but can activate transcription of ISREcontaining genes as a heterodimer with IRF-1 (Sharf et al., 1997) . In fact, phosphorylation events have been shown to enhance the ability of ICSBP to activate gene transcription through its interaction with IRF-1 (Sharf et al., 1997) . Thus, in addition to the increase in transcription induced by elevated levels of IRF-1 or ICSBP, IRF-1:ICSBP heterodimers afford additional opportunity to amplify the repertoire of IFNg target genes in DT mouse lens. As shown in Figure 7 , ICSBP and IRF-1 have overlapping, as well as, distinct effects on transcription of growth-regulatory genes: Whereas p21 WAF1 is induced by ICSBP and IRF-1, enhanced expression of p27 kip1 is detected mainly in aTN4-1/ ICSBP or aTN4-1 cells cultured in medium containing IFNg (Figure 7c ). Taken together, these results suggest that transcriptional activation of p21 WAF1 and p27 kip1 genes by ICSBP and/or IRF-1 plays a major role in regulating cell cycle progression in transformed lens cells and indicate that antiproliferative effects of IRF-1 and ICSBP in the DT lens are complementary and non-redundant. In contrast to the aT3 mouse, significant numbers of cells undergoing apoptosis are detected in the DT mouse lens, suggesting that cellular mechanism of apoptosis is compromised in aT3 lens, and that ability to activate apoptosis by IFNg contributes to remission of the lens tumor. Expression of caspase-1, a member of the caspase family of proteins that plays important roles in controlling programmed cell death in vertebrates, is detected in DT but not in aT3 lens (Figure 5a ). This result is consistent with reports showing that SV40-TAg decreases the cells' susceptibility to death by suppressing activity of caspase family proteins (Jung and Yuan, 1997) and underscores the role of caspase-induced apoptosis in mediating regression of the lens tumor. Our in vitro studies further reveal that caspase-1 expression is induced in aTN4-1 cells stimulated with IFNg and is markedly elevated in aTN4-1 cells overexpressing IRF-1 (aTN4-1/IRF-1) or ICSBP (aTN4-1/ICSBP) but not in aTN4-1 cells containing the empty vector (Figure 7c ), suggesting that its induction in SV40-TAgtransformed lens cells is mediated by IRF-1 and ICSBP (Figure 7c ). It is however interesting that in a recent report, responsiveness of metastatic colon carcinoma cells to IFNg is accompanied by enhanced expression of ICSBP and caspase-1 (Liu and Abrams, 2003) , suggesting that similar to IRF-1, ICSBP may have a direct effect on caspase-1 activation. Thus, although most focus on the role of IRF transcription factors as cell-cycle regulators and proapototic proteins has been on IRF-1 , these results suggest that ICSBP activates apoptosis and possesses more potent growth-inhibitory effects on lens carcinoma cells than IRF-1. Taken together with the enhanced expression of ICSBP and IRF-1 in DT mouse lens, our results are in line with other studies showing that apoptosis is induced in many tumor cell types through transcriptional activation of caspase-1 gene by IRF-1 (Horiuchi et al., 1999; Kano et al., 1999; Detjen et al., 2001; Tomita et al., 2003; Bowie et al., 2004) and ICSBP (Liu and Abrams, 2003) .
Regression of lens epithelial cell tumors in this aT3 animal model of SV40 T-Ag-induced tumor has implications for IFNg gene therapy in the treatment of cervical cancer, vaginal and vulvar cancer, malignant mesothelioma or other cancers for which DNA tumor viruses (SV40 virus or HPV16/18) are suspected to be the etiologic agents. The thrust of our data is that regression of the lens epithelial cell tumor is mediated by combined actions of STAT1, IRF-1 and ICSBP. However, we found that STAT1 is mainly required to transduce IFNg signals and activate transcription of IRF-1/ICSBP genes but is dispensable in downstream effects on growth or apoptosis. Thus, IFNg-inducible tumor suppressor, IRF-1 and ICSBP, can substitute for IFNg and directly activate antitumor mechanisms in malignant cells, thereby providing therapeutic benefits of IFNg without adverse effects that are normally associated with IFN therapy.
Materials and methods
Animals TR mice expressing SV40-TAg (aT3) or IFNg (IFNg-TR) in lens under direction of lens-specific aA-crystallin (À366/ þ 46) promoter element have previously been described (Lakso et al., 1992; Egwuagu et al., 1994) . Double TR (DT) mice co-expressing SV40-TAg and IFNg were generated by mating aT3 with IFNg-TR mice. All animal studies were performed in accordance with guidelines of the NIH Animal Care and Use Committee.
Histological and immunohistochemical analysis
Routine histopathology and immunohistochemical analysis of eyes and embryo heads were performed as described . Mouse monoclonal antibodies specific to SV40-TAg or proliferating cell nuclear antigen (PCNA) were purchased from Oncogene Research Products, Boston, Massachusetts. Control sections were incubated with appropriate normal serum and signal was visualized by the avidin-biotinperoxidase complex method (Vector Labs, Burlingame, CA, USA). Sections were counterstained with hematoxylin and eosin (H&E).
5-Bromo-2
0 -deoxy-uridine (BrdU) immunohistochemistry Pregnant females (20 days post mating) were killed 1 h after intravenous injection with BrdU at 100 mg/g body weight. Embryo heads were fixed in 10% formalin, embedded in paraffin, and sectioned at 5 mm. Endogenous peroxidase was blocked and immunodetection performed as recommended (BrdU kit II, Roche, Indianapolis, IN, USA).
In situ apoptosis detection In situ detection of apoptotic cells was performed using the ApopTag Plus kit (Oncor, Gaithersburg, MD, USA). Tissue sections (5 mm) of eyes from newborn WT or TR mouse litter mates were permeabilized and cellular DNA was tailed with digoxigenin-labeled nucleotides using deoxyribonucleotidyl transferase as previously described . Bound digoxigenin was detected using anti-digoxigenin antibody peroxidase conjugate, visualized with DAB chromagen and sections were counterstained in methyl green.
Polymerase chain reaction (PCR)
Total RNA and first-strand synthesis were performed as described . Caspase-1, FAS, E2F, p53, retinoblastoma (Rb), G3PDH and b-actin gene-specific primers used for PCR amplifications spanned at least an intron. For genotype analysis, tail DNA of the DT mice was screened using the following transgene primers: aAcry/SV40-TAg, 5 0 -TGCTTCATCCTCAGTAA GCACAGC-3 0 and 5 0 -CAGAGGCTCCTGTCTGACTCACTGC-3 0 ; aA-cry/IFNg, 5 0 -CAGAGGCTCCT GTCTGACTCACTGC-3 0 and 5 0 -CTG GATTCCGGCAACAGCTGGTGGAC-3 0 .
Western blot analysis
Western blotting was performed on whole cell extracts from 6-week-old mouse lenses (WT or TR litter-mate) or cultured lens cells as previously described . Antibodies used for immunodetection are IRF-1, ICSBP, IRF-2, p27, p53, caspase-1, b-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), SV40-TAg, pRb, p21 WAF1 (Oncogene) and pSTAT1 (Cell Signaling, Beverly, MA, USA). Mouse aA-crystallin antibody was kindly provided by Dr Sam Zigler (NIH). Preimmune serum was used in parallel as controls and signals were detected with horseradish peroxidase-conjugated-secondary F(ab 0 )2 Abs (Zymed Labs, San Francisco, CA, USA) using the ECL system (Amersham, Arlington Heights, IL, USA).
Cellular immune response aT3, or WT or DT mice (6-8 week-old) were primed i.p. with SV40-TAg protein (25 mg) in complete Freund's adjuvant. After 14 days, spleen or lymph node cells were assessed by the lymphocyte proliferation assay as detailed elsewhere (Yu et al., 2003) . In brief, 3 Â 10 5 CD4 þ T cells were cultured in quadruplet, in 0.2 ml RPMI 1640 medium (Bio-Whittaker, Walkersville, MD, USA) containing 2-mercaptoethanol (50 mM), irradiated syngeneic APC (10 Â ), with or without SV40-TAg. All lymphocyte samples were also tested for their response to PPD (5 mg/ml). Cultures were incubated for 72 h and pulsed with [ . SI values less than 3 are not statistically significant (Lai et al., 1998) .
Generation of lens cell lines expressing SV40-TAg and IRF-1 or ICSBP Coding sequence of mouse IRF-1 or ICSBP cDNA was subcloned into Not1 and Kpn1 sites of the mammalian expression vector, pCEP-4 (Invitrogen, Carlsbad, CA, USA). The sequence and orientation of each construct was verified by double-strand DNA sequencing. For generation of stable transfectants, plasmid cDNAs were purified by two sequential cesium chloride gradient banding and used to transfect a-TN4-1 cells (derived from aT2 lens epithelial cells tumors (Yamada et al., 1990) ) that constitutively express SV40-TAg by the Ca 2 þ -phosphate method. Single cell clones co-expressing SV40-TAg and IRF-1 (a-TN4-1/IRF-1) or SV40-TAg and ICSBP (a-TN4-1/ICSBP) or aTN4-1 cells containing the pCEP-4 vector (a-TN4-1/empty vector) were established by selection in 200 mg/ml of hygromycin B (Invitrogen).
Proliferation assay
To assess growth-regulatory effects of IFNg on SV40 T-Agtransformed lens cells, 100 000 (a-TN4-1/IRF-1, a-TN4-1/ ICSBP or aTN4-1) cells were seeded in 96-well plates (200 ml/ well) and cultured for 24 or 48 h in serum-free medium or medium containing mouse IFNg (100 U/ml). [ 3 H]thymidine (2 mCi/well) was added to cultures in the final 12 h of stimulation as described (Ebong et al., 2004b) . Each data point represents average of quadruplet cultures and results presented are representative of three independent experiments.
